PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Immunopharmacology, Shanghai Institute of MateriaMedica, Chinese Academy of Sciences, Shanghai, 201203, China.\', \'University of Chinese Academy of Sciences, Beijing, 100049, China.\', \'Laboratory of Immunology and Virology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.\', \'Laboratory of Immunopharmacology, Shanghai Institute of MateriaMedica, Chinese Academy of Sciences, Shanghai, 201203, China. xktong@simm.ac.cn.\', \'Laboratory of Immunopharmacology, Shanghai Institute of MateriaMedica, Chinese Academy of Sciences, Shanghai, 201203, China. jpzuo@simm.ac.cn.\', \'University of Chinese Academy of Sciences, Beijing, 100049, China. jpzuo@simm.ac.cn.\', \'Laboratory of Immunology and Virology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. jpzuo@simm.ac.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41401-020-0438-y
?:hasPublicationType
?:journal
  • Acta pharmacologica Sinica
is ?:pmid of
?:pmid
?:pmid
  • 32555446
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.173
?:rankingScore_hIndex
  • 73
?:title
  • Overview of therapeutic drug research for COVID-19 in China.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32555446>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32555446>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all